UNSPSC 51262911: Bopindolol malonate

This classification denotes an adrenergic beta-antagonist C23H28N2O3.C3H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S3UWR70991, chemically known as propanedioic acid, compd. with (+/-)-2-((1,1-dimethylethyl)amino)-1-(((2-methyl-1h-indol-4-yl)oxy)methyl)ethyl benzoate (1:1), but more generally known as bopindolol malonate, which bears US NIH Compound Identifier 636368. European Medicines Agency schedules Bopindolol malonate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00852MIG.

Most nations, for tariff and trade purposes, schedule bopindolol malonate under HS 29339990 and SITC 51577. As of Q4 2014, BOPINDOLOL MALONATE remains US FDA's Preferred Term for this commodity. SMILES: CC1CC2C([NH]1)CCCC2OCC(CNC(C)(C)C)OC(=O)C3CCCCC3.C(C(=O)O)C(=O)O.

UNSPSC 51262911 Bopindolol malonate is a Commodity code within pharmaceutical products, but state and local procurement activity under this code shows no relevant recent solicitations. The single recent opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—does not match the nominal scope of bopindolol malonate, a beta-blocker pharmaceutical compound. The naloxone procurement is an opioid-overdose reversal agent and deactivation system acquisition, which falls outside the cardiovascular pharmaceutical class that bopindolol represents. No state or local issuing bodies have posted opportunities for bopindolol malonate or related beta-blocker pharmaceuticals in the recent-opportunities dataset.

The source provides no evidence of current state or local government demand for bopindolol malonate specifically. Procurement under this Commodity code does not appear active in state and local markets at this time.